InsiderTrades.com logo

ONCY Insider Trading

Insider Ownership Percentage: 0.10%
Insider Buying (Last 12 Months): $104,000.00
Insider Selling (Last 12 Months): $0.00

Oncolytics Biotech Insider Trading History Chart

This chart shows the insider buying and selling history at Oncolytics Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oncolytics Biotech Share Price & Price History

Current Price: $1.27
Price Change: ▲ Price Increase of +0.1 (8.55%)
As of 01/22/2026 05:00 PM ET

This chart shows the closing price history over time for ONCY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Oncolytics Biotech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/16/2026Bernd R SeizingerDirectorBuy100,000$1.04$104,000.00466,991View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Oncolytics Biotech (NASDAQ:ONCY)

6.82% of Oncolytics Biotech stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ONCY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Oncolytics Biotech Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Scientech Research LLC18,204$25K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC382,051$0.54M0.0%N/A0.381%Search for SEC Filing on Google Icon
8/12/2025Seeds Investor LLC223,767$0.17M0.0%+17.8%0.230%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC66,939$61K0.0%+59.6%0.084%Search for SEC Filing on Google Icon
2/12/2025National Bank of Canada FI64,479$60K0.0%+199.6%0.081%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC98,452$90K0.0%N/A0.123%Search for SEC Filing on Google Icon
1/24/2025Vantage Point Financial LLC29,744$27K0.0%N/A0.037%Search for SEC Filing on Google Icon
1/8/2025International Assets Investment Management LLC200,400$0.19M0.0%+15.0%0.259%Search for SEC Filing on Google Icon
10/22/2024International Assets Investment Management LLC174,331$0.15M0.0%-12.1%0.228%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC51,889$55K0.0%N/A0.068%Search for SEC Filing on Google Icon
1/24/2024International Assets Investment Management LLC269,699$0.36M0.0%+33.9%0.362%Search for SEC Filing on Google Icon
1/12/2024Advisor Resource Council100,000$0.14M0.0%N/A0.134%Search for SEC Filing on Google Icon
1/11/2024Ausdal Financial Partners Inc.30,000$40K0.0%+50.0%0.041%Search for SEC Filing on Google Icon
11/8/2023Ausdal Financial Partners Inc.20,000$44K0.0%N/A0.027%Search for SEC Filing on Google Icon
10/13/2023Brave Asset Management Inc.25,000$55K0.0%+150.0%0.035%Search for SEC Filing on Google Icon
10/10/2023International Assets Investment Management LLC201,453$0.45M0.0%+3.3%0.278%Search for SEC Filing on Google Icon
10/4/2023International Assets Investment Management LLC201,453$0.45M0.0%+3.3%0.278%Search for SEC Filing on Google Icon
8/23/2023Headinvest LLC11,534$30K0.0%N/A0.016%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can32,380$85K0.0%N/A0.049%Search for SEC Filing on Google Icon
7/24/2023Brave Asset Management Inc.10,000$26K0.0%N/A0.015%Search for SEC Filing on Google Icon
7/20/2023International Assets Investment Management LLC194,963$0.51M0.1%+3.4%0.297%Search for SEC Filing on Google Icon
2/7/2023Lynwood Capital Management Inc.25,000$41K0.0%N/A0.041%Search for SEC Filing on Google Icon
1/24/2023International Assets Investment Management LLC169,111$0.61M0.1%-6.9%0.276%Search for SEC Filing on Google Icon
1/20/2023Newman Dignan & Sheerar Inc.18,915$31K0.0%+46.5%0.031%Search for SEC Filing on Google Icon
8/11/2022Toronto Dominion Bank35,362$34K0.0%N/A0.061%Search for SEC Filing on Google Icon
7/27/2022Advisor Resource Council100,000$0.10M0.0%N/A0.173%Search for SEC Filing on Google Icon
2/14/2022Long Focus Capital Management LLC40,000$56K0.0%N/A0.073%Search for SEC Filing on Google Icon
2/11/2022Advisor Resource Council100,000$0.14M0.0%N/A0.182%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC209,900$0.44M0.0%+812.6%0.382%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Oncolytics Biotech logo
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
Read More on Oncolytics Biotech

Today's Range

Now: $1.27
Low: $1.19
High: $1.30

50 Day Range

MA: $0.99
Low: $0.87
High: $1.17

52 Week Range

Now: $1.27
Low: $0.33
High: $1.51

Volume

3,055,432 shs

Average Volume

1,265,583 shs

Market Capitalization

$134.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97

Who are the company insiders with the largest holdings of Oncolytics Biotech?

Oncolytics Biotech's top insider shareholders include:
  1. Bernd R Seizinger (Director)
Learn More about top insider investors at Oncolytics Biotech.